New Delhi, Nov 11 (IANS) UK scientists are launching a trial to explore whether an ingredient commonly found in grape juice and wine could keep bowel cancer at bay.
Bowel cancer, also known as colorectal cancer, is a type of cancer that starts in the large bowel, including the colon and rectum.
The team will probe a chemical called resveratrol — a naturally occurring ingredient found in grapes, blueberries, raspberries, and peanuts — for potential cancer prevention.
The trial, led by researchers at the University of Leicester, UK, is also testing multiple potential prevention drugs for bowel cancer, including aspirin and metformin.
While drinking red wine does not prevent cancer, and is a major risk factor, the research focussed on purified resveratrol.
Karen Brown, Professor of Translational Cancer Research at the University of Leicester said that with advanced screening methods, early detection of bowel cancer has become easier. She further noted that the best way to prevent bowel cancer “is to improve our lifestyles — stopping smoking, maintaining a healthy weight, reducing alcohol consumption and having a healthy, balanced diet”.
However, with the new trial, funded by Cancer Research UK, the team aims to conduct a “unique experiment to see how drugs could stop bowel polyps from growing”.
Brown said the results can have wider “implications for how we prevent bowel cancer in people who are most likely to develop the disease as they get older.”
The team aims to enroll 1,300 patients at 60 locations in England and Wales.
Participants in the trial will have their polyps removed and will then receive a treatment – either aspirin or aspirin and metformin in the main trial or resveratrol or a placebo in the sub-study.
Those receiving aspirin or aspirin and metformin will take these drugs daily over three years, while those on resveratrol or the dummy tablet will take it for a year. Afterwards, all groups will be given colonoscopies to see if polyps have started growing again, and if so, how big they are compared to the ones removed at the start of the trial.
If the trial is successful, any of the treatments tested could be offered to people eligible for the NHS Bowel Screening Programme to reduce the chance of bowel polyps forming, and with that reduce the risk of bowel cancer in the future.
–IANS
rvt/
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
